Try our beta test site
1 study found for:    nct00752206
Show Display Options
Rank Status Study
1 Active, not recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.